Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer

BACKGROUND: Breast cancer (BC) is a prevalent disease that harms women's health, and in-depth investigations of the pathogenesis, treatment, and prevention of BC are the focus of many research programs. Chidamide (CHI) is a histone deacetylase suppressor that depresses histone deacetylase funct...

Descripción completa

Detalles Bibliográficos
Autor principal: Li, Jieqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111806/
https://www.ncbi.nlm.nih.gov/pubmed/37069549
http://dx.doi.org/10.1186/s12885-023-10774-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111806/
https://www.ncbi.nlm.nih.gov/pubmed/37069549
http://dx.doi.org/10.1186/s12885-023-10774-w

Ejemplares similares